Full thickness macular hole after intravitreal brolucizumab injection in neovascular age-related macular degeneration
Year: 2024
Type: article
Study design: Case Report
Abstract: PURPOSE: To describe a case of full thickness macular hole after intravitreal brolucizumab injection in neovascular age-related macular degeneration, which has not been reported to date. CASE DESCRIPTION: A 65-year-old male patient received brolucizumab intravitreal injection therapy for neovascular macular degeneration of the right eye. He received multiple intravitreal anti-VEGF injections on a pro re nata regimen and developed a full thickness macular hole. OUTCOME: Surgical treatment was performed with pars plana vitrectomy of the right eye. Full thickness macular hole was successfully treated. CONCLUSION: Although a full thickness macular hole following intravitreal brolucizumab injection is an uncommon complication, it requires caution.
Authors: Sang Hyeok Lee, Mee Yon Lee
Institution: Catholic University of Korea
Language: English
Topic: Retinal and Macular Surgery
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4402930402